[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key […]
Continue readingTag: Earnings
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
[ad_1] Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Kena Betancur | Corbis News | Getty Images Pfizer […]
Continue reading
Amgen scraps experimental weight loss pill, moves forward with injection
[ad_1] The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Thursday […]
Continue reading
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
[ad_1] Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a narrower-than-expected loss for the first quarter as the company’s cost-cutting efforts took […]
Continue reading
CVS shares plummet as health company slashes profit outlook on higher medical costs
[ad_1] CVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year profit outlook, citing higher medical costs that […]
Continue reading
Pfizer beats revenue estimates, raises profit outlook on cost cuts and smaller-than-feared drop in Covid drug sales
[ad_1] Jakub Porzycki | Nurphoto | Getty Images Pfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year profit outlook, benefiting from […]
Continue reading
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
[ad_1] Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little […]
Continue reading
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
[ad_1] Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. Mike Blake | Reuters Eli […]
Continue reading
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
[ad_1] Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but shortages are worsening , putting […]
Continue reading
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
[ad_1] The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on […]
Continue reading